Your browser doesn't support javascript.
loading
Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.
Wada, Koichiro; Tsuboi, Ichiro; Takahashi, Satoshi; Yasuda, Mitsuru; Miyazaki, Jun; Kobayashi, Kanao; Matsumoto, Masahiro; Hayami, Hiroshi; Yamamoto, Shingo; Kiyota, Hiroshi; Sato, Junko; Matsumoto, Tetsuya; Hasegawa, Naoki; Kobayashi, Intetsu; Masumori, Naoya; Kimura, Takahiro; Yamada, Hiroki; Matsumoto, Kazumasa; Ishikawa, Kiyohito; Fujimoto, Kiyohide; Shigemura, Katsumi; Sadahira, Takuya; Ito, Kenji; Yokoyama, Teruhiko; Izumitani, Masanobu; Sumii, Toru; Hosobe, Takahide; Hikosaka, Kazunobu; Kawahara, Motoshi; Sato, Takashi; Ito, Shin; Masue, Naruyasu; Sakurai, Takahiko; Kokura, Koji; Kadena, Hitoshi; Morikawa, Takamitsu; Minamidate, Yuzuru; Yoh, Mutsumasa; Hashimoto, Jiro; Maruyama, Takahiro; Yoshioka, Masaru; Takashima, Kenji; Kawai, Shuichi; Nishi, Shohei; Matsumoto, Tetsuro; Hirayama, Hideo; Okusa, Hiroshi; Uno, Satoshi; Inoue, Yoji; Kurimura, Yuichiro.
Afiliación
  • Wada K; Department of Urology, Shimane University Faculty of Medicine, Shimane, Japan; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tok
  • Tsuboi I; Department of Urology, Shimane University Faculty of Medicine, Shimane, Japan.
  • Takahashi S; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Med
  • Yasuda M; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Med
  • Miyazaki J; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, International University of Health and Welfar
  • Kobayashi K; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, Chugoku Rosai Hospital, Hiroshima, Japan.
  • Matsumoto M; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, University of Occupational and Environmental
  • Hayami H; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Blood Purification Center, Kagoshima University Hospital, Kagoshima,
  • Yamamoto S; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan; Department of Urology, Hyogo College of Medicine, Hyogo, Japan.
  • Kiyota H; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan; Department of Urology, School of Medicine, The Jikei University Katsushika Medical Center, Tokyo, Japan; Iguchi Nephrourology and Internal Medicine Clinic Shinkoiwa, Tokyo, Japan.
  • Sato J; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.
  • Matsumoto T; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.
  • Hasegawa N; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.
  • Kobayashi I; Department of Infection Control and Prevention, Toho University Faculty of Nursing, Tokyo, Japan.
  • Masumori N; Department of Urology, School of Medicine, Sapporo Medical University, Sapporo, Japan.
  • Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Yamada H; Department of Urology, School of Medicine, The Jikei University Katsushika Medical Center, Tokyo, Japan.
  • Matsumoto K; Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Ishikawa K; Department of Urology, School of Medicine, Fujita Health University, Aichi, Japan.
  • Fujimoto K; Department of Urology, Nara Medical University, Nara, Japan.
  • Shigemura K; Division of Urology, Kobe University, Kobe, Japan.
  • Sadahira T; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Ito K; Ito Urology Clinic, Kitakyushu, Japan.
  • Yokoyama T; Yokoyama Urological Clinic, Okayama, Japan.
  • Izumitani M; Izumitani Fureai Clinic, Nagoya, Japan.
  • Sumii T; Sumii Clinic, Hiroshima, Japan.
  • Hosobe T; Hosobe Clinic, Tokyo, Japan.
  • Hikosaka K; Hikosaka Clinic, Aichi, Japan.
  • Kawahara M; Kawahara Urology Clinic, Kagoshima, Japan.
  • Sato T; Nissin Urological Clinic, Hokkaido, Japan.
  • Ito S; iClinic, Miyagi, Japan.
  • Masue N; Masue Clinic, Gifu, Japan.
  • Sakurai T; Hanai Clinic, Aichi, Japan.
  • Kokura K; Kokura Clinic Urology, Hyogo, Japan.
  • Kadena H; Kadena Urology Clinic, Hiroshima, Japan.
  • Morikawa T; Mikawa Clinic, Aichi, Japan.
  • Minamidate Y; Fujinomori to U Clinic, Nagoya, Japan.
  • Yoh M; Yoh Urology and Dermatology Clinic, Aichi, Japan.
  • Hashimoto J; Teine Urological Clinic, Sapporo, Japan.
  • Maruyama T; Maruyama Urological Clinic, Nagoya, Japan.
  • Yoshioka M; Yoshioka Clinic Urology, Hyogo, Japan.
  • Takashima K; Takashima Urology Clinic, Nara, Japan.
  • Kawai S; Kawai Urology Clinic, Kitakyushu, Japan.
  • Nishi S; Nishi Urology and Dermatology Clinic, Kitakyushu, Japan.
  • Matsumoto T; Arm Clinic, Kitakyushu, Japan.
  • Hirayama H; Hirayama Urology Clinic, Kumamoto, Japan.
  • Okusa H; Ookusa Urology & Internal Medicine Clinic, Kanagawa, Japan.
  • Uno S; Hirajima Clinic, Okayama, Japan.
  • Inoue Y; Mori Urology Clinic, Hiroshima, Japan.
  • Kurimura Y; Koyo Urological Clinic, Hokkaido, Japan.
J Infect Chemother ; 30(4): 277-285, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38242285
ABSTRACT
The Japanese surveillance committee conducted a third nationwide surveillance of antimicrobial susceptibility of acute uncomplicated cystitis at 55 facilities throughout Japan between April 2020 and September 2021. In this surveillance, we investigated the susceptibility of Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), and Staphylococcus saprophyticus (S. saprophyticus) for various antimicrobial agents by isolating and culturing bacteria from urine samples. In total, 823 strains were isolated from 848 patients and 569 strains of target bacteria, including E. coli (n = 529, 92.9 %), K. pneumoniae (n = 28, 4.9 %), and S. saprophyticus (n = 12, 2.2 %) were isolated. The minimum inhibitory concentrations of 18 antibacterial agents were determined according to the Clinical and Laboratory Standards Institute manual. In premenopausal patients, there were 31 (10.5 %) and 20 (6.8 %) fluoroquinolone (FQ)-resistant E. coli and extended-spectrum ß-lactamase (ESBL)-producing E. coli, respectively. On the other hand, in postmenopausal patients, there were 75 (32.1 %) and 36 (15.4 %) FQ-resistant E. coli and ESBL-producing E. coli, respectively. The rate of FQ-resistant E. coli and ESBL-producing E. coli in post-menopausal women was higher than that for our previous nationwide surveillance (20.7 % and 32.1 % p = 0.0004, 10.0 % and 15.4 %; p = 0.0259). For pre-menopausal women, there was no significant difference in the rate of FQ-resistant E. coli and ESBL-producing E. coli between this and previous reports, but the frequency of FQ-resistant E. coli and ESBL-producing E. coli exhibited a gradual increase. For appropriate antimicrobial agent selection and usage, it is essential for clinicians to be aware of the high rate of these antimicrobial-resistant bacteria in acute uncomplicated cystitis in Japan.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cistitis / Escherichia coli Tipo de estudio: Guideline / Screening_studies Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cistitis / Escherichia coli Tipo de estudio: Guideline / Screening_studies Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2024 Tipo del documento: Article